UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Programmed Death Ligand 1 Is Expressed by Non―Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells

Clinical cancer research, 2011-07, Vol.17 (13), p.4232-4244

2011

Link zum Volltext

Verfügbarkeit prüfen

Exploring treatment decision-making in chronic myeloid leukemia in chronic phase

Frontiers in oncology, 2024-07, Vol.14, p.1369246

2024

Link zum Volltext

Verfügbarkeit prüfen

Insights into lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentary

Clinical advances in hematology & oncology, 2018-09, Vol.16 Suppl 16 (9), p.13-15

Andorsky, David J

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Acceptance and Commitment Therapy for Anxious Cancer Survivors in Community Clinics: Outcomes and Moderators

Journal of consulting and clinical psychology, 2021-04, Vol.89 (4), p.327-340

2021

Link zum Volltext

Verfügbarkeit prüfen

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma

British journal of haematology, 2019-01, Vol.184 (2), p.215-222

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

Clinical cancer research, 2012-10, Vol.18 (20), p.5752-5760

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): study protocol

BMC cancer, 2019-01, Vol.19 (1), p.89-89, Article 89

2019

Link zum Volltext

Verfügbarkeit prüfen

BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma

Future oncology (London, England), 2022-11, Vol.18 (36), p.3961-3969

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of a multi-modal palliative care intervention to promote advance care planning and psychological well-being among adults with advanced cancer: study protocol

BMC palliative care, 2022-11, Vol.21 (1), p.1-198, Article 198

2022

Link zum Volltext

Verfügbarkeit prüfen

MCL-135 BRUIN MCL-321, a Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress)

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22 Suppl 2, p.S395-S396

2022

Link zum Volltext

Verfügbarkeit prüfen

Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes

The Journal of pediatrics, 2001-07, Vol.139 (1), p.27-33

2001

Link zum Volltext

Verfügbarkeit prüfen

Anxiety and Depression in Metastatic Cancer: A Critical Review of Negative Impacts on Advance Care Planning and End-of-Life Decision Making With Practical Recommendations

JCO oncology practice, 2023-12, Vol.19 (12), p.1097

2023

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-21: biology and application to cancer therapy

Expert opinion on biological therapy, 2008-09, Vol.8 (9), p.1295-1307

2008

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

The New England journal of medicine, 2019-02, Vol.380 (8), p.720-728

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study

British journal of haematology, 2021-02, Vol.192 (4), p.737-746

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Trial to Evaluate Safety of Subcutaneous Epcoritamab Monotherapy in the Outpatient Setting Among Patients with Relapsed or Refractory Diffuse Grade 1-3a Large B-Cell and Follicular Lymphoma (EPCORE NHL-6)

Blood, 2022-11, Vol.140 (Supplement 1), p.9491-9492

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting

Blood, 2019-11, Vol.134 (Supplement_1), p.2810-2810

2019

Link zum Volltext

Verfügbarkeit prüfen

Trial in Progress: Asciminib in Monotherapy 4 CML (AIM4CML), a Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase without or with T315I Mutations

Blood, 2021-11, Vol.138 (Supplement 1), p.3599-3599

2021

Link zum Volltext

Verfügbarkeit prüfen

POSTER: CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study of Asciminib vs Nilotinib in Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S178-S178

2023

Link zum Volltext

Verfügbarkeit prüfen

CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study of Asciminib vs Nilotinib in Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S349-S350

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment Patterns and Outcomes of 159 Ibrutinib-Treated MCL Patients in the United States: A Retrospective Electronic Medical Record Database and Chart Review Study

Blood, 2018-11, Vol.132 (Supplement 1), p.4163-4163

2018

Link zum Volltext

Verfügbarkeit prüfen

Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)

British journal of haematology, 2020-01, Vol.188 (2), p.240-248

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(71)
Berichte
(1)

Sprache

Englisch
(72)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Programmed Death Ligand 1 Is Expressed by Non―Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells

Exploring treatment decision-making in chronic myeloid leukemia in chronic phase

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Insights into lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentary

Randomized Trial of Acceptance and Commitment Therapy for Anxious Cancer Survivors in Community Clinics: Outcomes and Moderators

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma

A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): study protocol

BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma

A randomized controlled trial of a multi-modal palliative care intervention to promote advance care planning and psychological well-being among adults with advanced cancer: study protocol

MCL-135 BRUIN MCL-321, a Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress)

Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes

Anxiety and Depression in Metastatic Cancer: A Critical Review of Negative Impacts on Advance Care Planning and End-of-Life Decision Making With Practical Recommendations

Interleukin-21: biology and application to cancer therapy

Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study

Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial

Phase 2 Trial to Evaluate Safety of Subcutaneous Epcoritamab Monotherapy in the Outpatient Setting Among Patients with Relapsed or Refractory Diffuse Grade 1-3a Large B-Cell and Follicular Lymphoma (EPCORE NHL-6)

Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting

Trial in Progress: Asciminib in Monotherapy 4 CML (AIM4CML), a Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase without or with T315I Mutations

POSTER: CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study of Asciminib vs Nilotinib in Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study of Asciminib vs Nilotinib in Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Treatment Patterns and Outcomes of 159 Ibrutinib-Treated MCL Patients in the United States: A Retrospective Electronic Medical Record Database and Chart Review Study

Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)

Suchergebnisse filtern